Find information on thousands of medical conditions and prescription drugs.

Invirase

Saquinavir, with trade name Fortovase® is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART). more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Saquinavir mesylate is a different formulation, designed to be combined with another protease inhibitor that increases the bioavailability of the saquinavir.

History

Saquinavir was the first protease inhibitor (and sixth antiretroviral) approved by the Food and Drug Administration (FDA). It was approved on December 6, 1995, as Invirase®, a poorly-absorbed hard gel capsule which quickly led to viral resistance in many of the pioneer patients.

It was approved again on Nov 7, 1997 as Fortovase®, a soft gel capsule reformulated for improved bioavailability. The manufacturer, Roche, is alleged to have rushed Invirase® to market, but the conditions that prevailed at the time were very bad and there was a lot of pressure to produce products quickly.

Method of activity

When given alone, the HIV Protease Inhibitor (HPI) saquinavir has a very low oral bioavailability. In the clinic, it was found that the oral bioavailability of saquinavir significantly increases when patients also receive the HPI ritonavir. For patients, this has the major benefit that they can take less saquinavir, while maintaining sufficient saquinavir blood plasma levels to efficiently suppress the replication of HIV.

The mechanism behind this welcome observation was not directly known, but later it was determined that ritonavir inhibits the enzyme Cytochrome P450 3A4. Normally, this enzyme metabolizes saquinavir to an inactive form, but with the ritonavir inhibiting this enzyme, the saquinavir blood plasma levels increased considerably. Additionally, ritonavir also inhibits multidrug transporters, although to a much lower extent.


Read more at Wikipedia.org


[List your site here Free!]



SAQUINAVIR - Fortovase or Invirase
The 200 mg saquinavir soft-gel capsules are beige, opaque, soft gelatin capsules imprinted with "ROCHE" and "0246". Other formulations of saquinavir ...
Therapeutic and diagnostic advances in the HAART era
It has been almost 10 years since the approval of the first protease inhibitor, saquinavir (Invirase) in December 1995. Since that time, there have been great advances in treatment monitoring, trea
HAART at 10—a CFA timeline
Please note: the events and trends listed on this timeline are by year only and are not listed in any particular order within each year. The sources ...
Ten years of HAART
The year 1996 has brought a sea change in AIDS research and treatment. Three major factors have contributed to this sea change: a new understanding of viral pathogenesis, new and powerful antiretro
One! Two pharmaceutical giants team up to find a simpler, better way to fight HIV
Treating HIV disease could become a lot easier for many people who are on a medication regimen. Two of the world's pharmaceutical giants--Bristol-Myers ...
Weekend treatment interruptions for certain well-controlled patients: interview with Cal Cohen, M.D
Dr. Cal Cohen is the research director of the Community Research Initiative of New England, teaches at Harvard Medical School in Boston, and is affiliated ...
Investigational drugs available - Invirase by Hoffmannn-LaRoche for AIDS and riluzole by Rhone-Poulenc Rorer for Lou Gehrig's disease in investigational
Two investigational drugs--one for HIV infection and the other for Lou Gehrig's disease--have joined the growing list of treatments FDA is making available ...
Take a pill break - HIV Digest - intermittent drug therapy in AIDS treatment; includes related notes - Brief Article
People with AIDS may be able to take weeklong vacations from their drug regimens, according to a study at the National Institute of Allergy and Infectious ...

Home Contact Resources Exchange Links ebay